- Home
- BVS vs ORGO Comparison
BVS vs ORGO Comparison
Compare BVS & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVS
- ORGO
- Stock Information
- Founded
- BVS 2011
- ORGO 1985
- Country
- BVS United States
- ORGO United States
- Employees
- BVS N/A
- ORGO N/A
- Industry
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- BVS Health Care
- ORGO Health Care
- Exchange
- BVS Nasdaq
- ORGO Nasdaq
- Market Cap
- BVS 656.9M
- ORGO 665.8M
- IPO Year
- BVS 2021
- ORGO N/A
- Fundamental
- Price
- BVS $7.82
- ORGO $4.22
- Analyst Decision
- BVS Strong Buy
- ORGO Buy
- Analyst Count
- BVS 4
- ORGO 2
- Target Price
- BVS $15.00
- ORGO $5.50
- AVG Volume (30 Days)
- BVS 339.2K
- ORGO 1.4M
- Earning Date
- BVS 05-06-2025
- ORGO 05-08-2025
- Dividend Yield
- BVS N/A
- ORGO N/A
- EPS Growth
- BVS N/A
- ORGO N/A
- EPS
- BVS N/A
- ORGO N/A
- Revenue
- BVS $573,280,000.00
- ORGO $482,043,000.00
- Revenue This Year
- BVS N/A
- ORGO $3.31
- Revenue Next Year
- BVS $6.09
- ORGO $12.50
- P/E Ratio
- BVS N/A
- ORGO N/A
- Revenue Growth
- BVS 11.89
- ORGO 11.29
- 52 Week Low
- BVS $3.90
- ORGO $2.17
- 52 Week High
- BVS $14.38
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- BVS 37.22
- ORGO 47.71
- Support Level
- BVS $7.56
- ORGO $3.57
- Resistance Level
- BVS $8.66
- ORGO $4.38
- Average True Range (ATR)
- BVS 0.61
- ORGO 0.34
- MACD
- BVS -0.05
- ORGO -0.00
- Stochastic Oscillator
- BVS 28.40
- ORGO 75.27
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.